Anktiva N-803 plus BCG Vaccine — Vax-Before-Travel

Anktiva N-803 plus BCG Vaccine

Fact checked by Robert Carlson, MD

May 4

4 min read

Enhanced Recombinant BCG Vaccine Awaits FDA Approval

Serum Institute of India produces recombinant BCG vaccine

BCG vaccine

Fact checked by Robert Carlson, MD

Feb 5

4 min read

Bladder Cancer Vaccine Therapy Offers Favorable Risk-Benefit Ratio

N-803 plus BCG bladder cancer vaccine therapy candidate has Prescription Drug User Fee Act date of April 23, 2024

BCG vaccine cancer

Fact checked by Holly Lutmer PharmD

Oct 23

5 min read

Non-Muscle-Invasive Bladder Cancer Vaccine Candidate Competes Resubmission to US FDA

Anktiva N-803 is a first-in-class IL-15 superagonist plus BCG vaccine

Bladder cancer vaccine 2023